Literature DB >> 18547067

Mechanistic insights into the Michael addition of deoxyguanosine to catechol estrogen-3,4-quinones.

Douglas E Stack1, Guangping Li, Anastacia Hill, Nicholas Hoffman.   

Abstract

The reaction of catechol estrogen quinones with DNA to produce the depurinating adducts, 4-OHE 2(E 1)-1-N7Gua and 4-OHE 2(E 1)-1-N3Ade, has been linked to the initiation of breast and other human cancers. A better understanding into the mechanism of how these adducts are formed would be useful to studies aimed at correlating adduct formation to DNA damage. Possible reaction intermediates, produced as a result of Michael addition of deoxyguanosine (dG) to catechol estrogen-3,4-quninones, have been modeled using density functional theory to determine likely intermediates on the potential energy surface (PES) of this reaction. Specifically, the sequence of elimination events, glycosidic bond cleavage and rearomatization of the estrogen A ring, was explored. Consistent with known experimental procedures, B3LYP calculations indicate that a proton source is needed to effect the Michael addition. Calculations also indicate that a catalytic mechanism, where one catechol estrogen quinone could adduct multiple purine bases, is unlikely. Experimental investigation toward an observed cationic reaction intermediate was also consistent with a stoichiometric reaction between estrone-3,4-quinone (E 1-3,4-Q) and dG. HPLC-MS analysis indicates that the cationic reaction intermediate contains the 2'-deoxyribose moiety. Assay of 4-OHE 1-1-N7Gua adduct formation and 2'-deoxyribose formation at different times during the reaction of E 1-3,4-Q with dG indicates that equimolar amounts of each are produced, further supporting a stoichiometric process with respect the catechol estrogen quinone. Differences in the UV spectroscopy of cationic reaction intermediate and the 4-OHE 1-1-N7Gua adduct allowed for kinetic analysis of the glycosidic bond cleavage process. Kinetic scanning analysis indicates that the decomposition of the cationic reaction intermediate is a first-order process with a t 1/2 of 40 min at 30 degrees C. Measurement of the unimolecular rate constant k at different temperatures afforded an Arrhenius plot, which provided values for Delta H, Delta S, and Delta G of 24.7 kcal/mol, 7.2 eu, and 26.8 kcal/mol, respectively. The computational data in conjunction with experimental results are consistent with a mechanism that involves a proton-assisted Michael addition to form an alpha-ketoenol ring system, followed by slow loss of the proton at C1 to restore the aromatic A ring, then fast cleavage of the glycosidic bond to form the 4-OHE 1-1-N7Gua adduct.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547067     DOI: 10.1021/tx800071u

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  7 in total

Review 1.  The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Authors:  Ercole Cavalieri; Eleanor Rogan
Journal:  Mol Aspects Med       Date:  2013-08-30

Review 2.  Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  J Steroid Biochem Mol Biol       Date:  2011-03-21       Impact factor: 4.292

3.  Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease.

Authors:  Muhammad Zahid; Muhammad Saeed; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Free Radic Biol Med       Date:  2009-11-10       Impact factor: 7.376

4.  The etiology and prevention of breast cancer.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  Drug Discov Today Dis Mech       Date:  2012

5.  Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate.

Authors:  Douglas E Stack
Journal:  Metabolites       Date:  2015-09-10

6.  Association between polymorphisms in estrogen metabolism genes and breast cancer development in Chinese women: A prospective case-control study.

Authors:  Juanjuan Qiu; Zhenggui Du; Jingping Liu; Yi Zhou; Faqing Liang; Qing Lü
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

7.  Potential Cancer- and Alzheimer's Disease-Targeting Phosphodiesterase Inhibitors from Uvaria alba: Insights from In Vitro and Consensus Virtual Screening.

Authors:  Mark Tristan Quimque; Kin Israel Notarte; Arianne Letada; Rey Arturo Fernandez; Delfin Yñigo Pilapil; Kirstin Rhys Pueblos; Jay Carl Agbay; Hans-Martin Dahse; Arlette Wenzel-Storjohann; Deniz Tasdemir; Abbas Khan; Dong-Qing Wei; Allan Patrick Gose Macabeo
Journal:  ACS Omega       Date:  2021-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.